Abstract
Objective To evaluate the potential clinical value of quantitative functional FDG PET and pathological amyloid-β PET with cerebrospinal fluid (CSF) biomarkers and clinical assessments in the prediction of Alzheimer's disease (AD) progression.
| Original language | English (US) |
|---|---|
| Article number | e0154406 |
| Journal | PLoS One |
| Volume | 11 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Agricultural and Biological Sciences(all)
- Biochemistry, Genetics and Molecular Biology(all)
- Medicine(all)
Cite this
Potential clinical value of multiparametric pet in the prediction of Alzheimer's disease progression. / Alzheimer's Disease NeuroimagingInitiative.
In: PLoS One, Vol. 11, No. 5, e0154406, 01.05.2016.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Potential clinical value of multiparametric pet in the prediction of Alzheimer's disease progression
AU - Alzheimer's Disease NeuroimagingInitiative
AU - Chen, Xueqi
AU - Zhou, Yun
AU - Wang, Rongfu
AU - Cao, Haoyin
AU - Reid, Savina
AU - Gao, Rui
AU - Han, Dong
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Objective To evaluate the potential clinical value of quantitative functional FDG PET and pathological amyloid-β PET with cerebrospinal fluid (CSF) biomarkers and clinical assessments in the prediction of Alzheimer's disease (AD) progression.
AB - Objective To evaluate the potential clinical value of quantitative functional FDG PET and pathological amyloid-β PET with cerebrospinal fluid (CSF) biomarkers and clinical assessments in the prediction of Alzheimer's disease (AD) progression.
UR - http://www.scopus.com/inward/record.url?scp=84969150990&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969150990&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0154406
DO - 10.1371/journal.pone.0154406
M3 - Article
VL - 11
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 5
M1 - e0154406
ER -